| - GRCh37:
- Chr16:17211793
- GRCh38:
- Chr16:17117936
| XYLT1 | F756C | Desbuquois dysplasia 2 | Uncertain significance | criteria provided, single submitter |
| - GRCh37:
- Chr16:17294463
- GRCh38:
- Chr16:17200606
| XYLT1 | M321R | Desbuquois dysplasia 2 | Uncertain significance (Aug 26, 2020) | criteria provided, single submitter |
| - GRCh37:
- Chr16:17202664
- GRCh38:
- Chr16:17108807
| XYLT1 | G923D | Desbuquois dysplasia 1, Desbuquois dysplasia 2 | Uncertain significance (Aug 5, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17221755
- GRCh38:
- Chr16:17127898
| XYLT1 | | not provided, Desbuquois dysplasia 2 | Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17294295
- GRCh38:
- Chr16:17200438
| XYLT1 | | not provided, Desbuquois dysplasia 2 | Benign (Dec 5, 2021) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17232325
- GRCh38:
- Chr16:17138468
| LOC102723692, XYLT1 | R551C | not provided, Desbuquois dysplasia 2 | Pathogenic (Apr 17, 2023) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17228363
- GRCh38:
- Chr16:17134506
| XYLT1, LOC102723692 | T665M | Desbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
| Benign (Nov 3, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17211848
- GRCh38:
- Chr16:17117991
| XYLT1 | | Desbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17292074
- GRCh38:
- Chr16:17198217
| XYLT1 | | Desbuquois dysplasia 2, Desbuquois dysplasia 1, not provided
| Benign (Oct 30, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17211729
- GRCh38:
- Chr16:17117872
| XYLT1 | | Desbuquois dysplasia 1, Desbuquois dysplasia 2, not provided
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17211545
- GRCh38:
- Chr16:17117688
| XYLT1 | V839I | not provided, Desbuquois dysplasia 1, Desbuquois dysplasia 2
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17353090
- GRCh38:
- Chr16:17259233
| XYLT1 | A223G | Desbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17228368
- GRCh38:
- Chr16:17134511
| XYLT1, LOC102723692 | | Desbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17202757
- GRCh38:
- Chr16:17108900
| XYLT1 | R892Q | Desbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17202801
- GRCh38:
- Chr16:17108944
| XYLT1 | | Desbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
| Benign (Nov 4, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17352836
- GRCh38:
- Chr16:17258979
| XYLT1 | | Desbuquois dysplasia 1, Desbuquois dysplasia 2, not provided
| Benign (Oct 22, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17294348
- GRCh38:
- Chr16:17200491
| XYLT1 | | not provided, Desbuquois dysplasia 2, Desbuquois dysplasia 1
| Benign/Likely benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17292142
- GRCh38:
- Chr16:17198285
| XYLT1 | R406W | Desbuquois dysplasia 1, Desbuquois dysplasia 2, not provided
| Uncertain significance (Jul 11, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17202777
- GRCh38:
- Chr16:17108920
| XYLT1 | | Desbuquois dysplasia 1, Desbuquois dysplasia 2, not provided
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17252767
- GRCh38:
- Chr16:17158910
| XYLT1 | | Desbuquois dysplasia 2 | Pathogenic (Feb 28, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr16:17564348-17564373
- GRCh38:
- Chr16:17470491-17470516
| XYLT1 | Q94fs | Desbuquois dysplasia 2 | Pathogenic (Feb 28, 2019) | no assertion criteria provided |
| - GRCh38:
- Chr16:472169
| XYLT1 | | Desbuquois dysplasia 2 | Pathogenic (Nov 7, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr16:17564335
- GRCh38:
- Chr16:17470478
| XYLT1 | G107* | Desbuquois dysplasia 2 | Pathogenic (Feb 28, 2019) | no assertion criteria provided |
| - GRCh37:
- Chr16:17232220
- GRCh38:
- Chr16:17138363
| LOC102723692, XYLT1 | R586C | Desbuquois dysplasia 1, Pseudoxanthoma elasticum, Desbuquois dysplasia 2
| Uncertain significance (Oct 12, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17232242-17232243
- GRCh38:
- Chr16:17138385-17138386
| LOC102723692, XYLT1 | | not provided | Pathogenic (Apr 20, 2017) | criteria provided, single submitter |
| - GRCh37:
- Chr16:17252768
- GRCh38:
- Chr16:17158911
| XYLT1 | | Desbuquois dysplasia 2 | Pathogenic (Mar 6, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr16:17232391
- GRCh38:
- Chr16:17138534
| LOC102723692, XYLT1 | | Desbuquois dysplasia 2, Pseudoxanthoma elasticum, not provided, Desbuquois dysplasia 1 | Likely benign (Oct 21, 2022) | criteria provided, multiple submitters, no conflicts |
| - GRCh37:
- Chr16:17564377-17564378
- GRCh38:
- Chr16:17470520-17470521
| XYLT1 | P93fs | Desbuquois dysplasia 2 | Pathogenic (Mar 6, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr16:17353319
- GRCh38:
- Chr16:17259462
| XYLT1, LOC130058566 | R147* | Desbuquois dysplasia 2 | Pathogenic (Mar 6, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr16:17228565
- GRCh38:
- Chr16:17134708
| XYLT1, LOC102723692 | R598C | Desbuquois dysplasia 1 | Uncertain significance (Sep 1, 2021) | criteria provided, single submitter |
| - GRCh37:
- Chr16:17235156
- GRCh38:
- Chr16:17141299
| XYLT1 | R481W | Desbuquois dysplasia 2 | Pathogenic (Jan 1, 2014) | no assertion criteria provided |
| - GRCh37:
- Chr16:17564311
- GRCh38:
- Chr16:17470454
| XYLT1 | A115S | Desbuquois dysplasia 2, not provided, Desbuquois dysplasia 1
| Benign (Nov 1, 2022) | criteria provided, multiple submitters, no conflicts |